1. Home
  2. SSP vs OBIO Comparison

SSP vs OBIO Comparison

Compare SSP & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo E.W. Scripps Company (The)

SSP

E.W. Scripps Company (The)

HOLD

Current Price

$2.75

Market Cap

264.6M

Sector

Industrials

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$3.92

Market Cap

240.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSP
OBIO
Founded
1878
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.6M
240.7M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
SSP
OBIO
Price
$2.75
$3.92
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$6.95
$14.25
AVG Volume (30 Days)
574.7K
213.9K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.13
EPS
N/A
N/A
Revenue
$2,150,585,000.00
$33,482,000.00
Revenue This Year
$8.34
N/A
Revenue Next Year
N/A
$12.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$2.04
$2.20
52 Week High
$5.39
$5.42

Technical Indicators

Market Signals
Indicator
SSP
OBIO
Relative Strength Index (RSI) 29.81 46.70
Support Level $2.73 $3.77
Resistance Level $3.01 $4.18
Average True Range (ATR) 0.21 0.19
MACD -0.04 -0.00
Stochastic Oscillator 21.37 37.50

Price Performance

Historical Comparison
SSP
OBIO

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: